BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Lockheed Martin Corporation and ZyGEM Corporation Accelerate DNA Identification for Law Enforcement, Homeland Security and Defense Communities


9/22/2010 8:54:49 AM

TAMPA, Fla., Sept. 22 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) and ZyGEM Corp. Ltd. today are unveiling a new DNA analysis system that has potential to transform how law enforcement, homeland security and defense communities use DNA-based identification in support of their missions.

The prototype, called RapI.D., will be previewed at a 2010 Biometric Consortium Conference special session on Rapid DNA. The day-long session is sponsored by the FBI's Criminal Justice Information Services (CJIS) division.

"Our law enforcement, homeland security and defense communities face a significant challenge in how quickly they can confirm an individual's identity," said John Mears, director, Lockheed Martin Biometric Solutions. "Our goal with the RapI.D. sample-to-answer DNA analysis device is to transform today's DNA identification process from one that takes a great deal of training, sophisticated equipment and days or weeks to complete, into an affordable, on-site process that takes less than an hour."

Developed in collaboration with ZyGEM as a Lockheed Martin Technology Innovation Initiative, RapI.D. leverages the latest in microfluidic research and development to accelerate the DNA identification processessentially building a laboratory on a small, single chip that reduces the processing steps and time needed for analysis. The RapI.D. platform is currently in prototype at ZyGEM's Charlottesville, Va., MicroLab laboratories, with a Beta version expected to be released for testing in select laboratories early next year.

"ZyGEM's MicroLab technology has been developed with the goal of dramatically reducing today's complex analytic approaches. The result is a compact platform that can analyze DNA simply, accurately and rapidly, enabling DNA identification to be used more widely and in many more settings." explained ZyGEM CEO Paul Kinnon. "Forensic and other federal, state and local government applications represent critical near-term markets for our technology, and we are delighted to have Lockheed Martin as a key teammate in the development of our first systems."

The cost and complexity of current forensic DNA analysis methods has contributed to significant processing backlogs throughout the criminal justice system. Data from the Justice Department's FY 2009 Forensic DNA Backlog Reduction Program suggest that the backlog has increased in recent years, indicating that the 2008 backlogged cases reported by state and local government applicants for funding under the program had nearly tripled compared to comparable data from 2005.

Headquartered in Bethesda, Md., Lockheed Martin is a global security company that employs about 136,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The Corporation's 2009 sales from continuing operations were $44.5 billion.

ZyGEM Corporation is developing innovative products for the analysis of DNA and other nucleic acids. ZyGEM currently markets nucleic acid extraction solutions based on the company's exclusive collection of microorganisms from extreme environments, with applications in basic research, forensics, clinical diagnostics and agriculture. ZyGEM's MicroLab unit is developing integrated sample-to-answer systems with the potential to revolutionize DNA testing for the many applications where accuracy, speed, ease-of-use and accessibility are important.

For additional information, visit our Web sites:

http://www.lockheedmartin.com

http://www.zygem.com

SOURCE Lockheed Martin


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->